Conversely, VHL overexpression in VHL-null 786O and UMRC2 ccRCC cells led to increased METTL3/METTL14 binding (Figure 3B and Supplemental Figure 3E). This evidence concerns the gene METTL14 and nonpapillary renal cell carcinoma.